Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Am Heart J. 2017 Jun 9;191:21–29. doi: 10.1016/j.ahj.2017.06.002

Table III.

Bayesian analysis* of ICD efficacy among NYHA II and III patients

Group HR Lower PCI Upper PCI
DEFINITE 0.65 0.42 0.93
MADIT I 0.59 0.31 0.81
MADIT II 0.61 0.44 0.80
SCD-HeFT 0.72 0.61 0.87
Overall 0.65 0.40 0.99

PCI, 95% posterior credible interval.

*

Adjusted for age, sex, race, ejection fraction, QRS duration >120 milliseconds, ischemic heart disease, antiarrhythmic drug use, β-blockers, ACE inhibitors, smoking, and diabetes.